TEK and neoplasm: Cytokines and chemokines produced by tumor cells can inhibit T lymphocyte crossing of the tumor vasculature by reducing endothelial cell expression of adhesion molecules, while functioning as chemoattractants for immunosuppressive leukocytes such as T regulatory cells, Tie2+ monocytes, or myeloid-derived suppressor cells.